India s Subject Expert Committee (SEC) on Covid-19 has granted emergency use approval to Bharat Biotech s Covaxin for children in the 2-18 years age group. MORE..

India s Subject Expert Committee (SEC) on Covid-19 has granted emergency use approval to Bharat Biotech s Covaxin for children in the 2-18 years age group. MORE..

from AdaDerana RSS https://ift.tt/3v8KhTr
via IFTTT